Table 2 compared thyroid hormone profiles and autoantibody levels between the thyrotoxicosis (n = 71) and hypothyroidism (n = 87) subgroups of patients who developed thyroid immune-related adverse events (irAEs) following immune checkpoint inhibitor (ICI) therapy. This evidence concerns the gene TG and thyroid gland disorder.